Waheed Sangrar

754 total citations
24 papers, 591 citations indexed

About

Waheed Sangrar is a scholar working on Molecular Biology, Cancer Research and Hematology. According to data from OpenAlex, Waheed Sangrar has authored 24 papers receiving a total of 591 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Cancer Research and 8 papers in Hematology. Recurrent topics in Waheed Sangrar's work include Protease and Inhibitor Mechanisms (9 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Waheed Sangrar is often cited by papers focused on Protease and Inhibitor Mechanisms (9 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Waheed Sangrar collaborates with scholars based in Canada, Bangladesh and United States. Waheed Sangrar's co-authors include Marlys L. Koschinsky, Peter A. Greer, Santica M. Marcovina, Yan Gao, Michael E. Nesheim, Peter Truesdell, Mark A. Hancock, Michelle Scott, Laszlo Bajzar and Ralph Zirngibl and has published in prestigious journals such as Circulation, Molecular and Cellular Biology and Biochemistry.

In The Last Decade

Waheed Sangrar

24 papers receiving 579 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Waheed Sangrar Canada 14 230 215 178 103 88 24 591
Yi Shi China 15 138 0.6× 387 1.8× 286 1.6× 62 0.6× 94 1.1× 36 701
P. Charles Lin United States 10 48 0.2× 417 1.9× 194 1.1× 124 1.2× 232 2.6× 11 799
Anna Roubtsova Canada 11 608 2.6× 199 0.9× 137 0.8× 143 1.4× 49 0.6× 17 786
Kévin Ly Canada 11 246 1.1× 218 1.0× 103 0.6× 119 1.2× 74 0.8× 20 530
Jose Juarez United States 10 60 0.3× 377 1.8× 422 2.4× 66 0.6× 246 2.8× 15 747
Qianshan Ding China 19 73 0.3× 526 2.4× 254 1.4× 146 1.4× 193 2.2× 42 870
Mark Peek United States 9 59 0.3× 219 1.0× 50 0.3× 42 0.4× 60 0.7× 9 456
Monica Kong-Beltran United States 10 302 1.3× 471 2.2× 149 0.8× 72 0.7× 219 2.5× 11 918
Ali Küpelioğlu Türkiye 15 155 0.7× 181 0.8× 158 0.9× 40 0.4× 246 2.8× 39 578
Ling‐Yuh Huw United States 15 68 0.3× 254 1.2× 142 0.8× 82 0.8× 273 3.1× 26 654

Countries citing papers authored by Waheed Sangrar

Since Specialization
Citations

This map shows the geographic impact of Waheed Sangrar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Waheed Sangrar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Waheed Sangrar more than expected).

Fields of papers citing papers by Waheed Sangrar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Waheed Sangrar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Waheed Sangrar. The network helps show where Waheed Sangrar may publish in the future.

Co-authorship network of co-authors of Waheed Sangrar

This figure shows the co-authorship network connecting the top 25 collaborators of Waheed Sangrar. A scholar is included among the top collaborators of Waheed Sangrar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Waheed Sangrar. Waheed Sangrar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khanal, Prem, Melissa Mitchell, Zhilin Chen, et al.. (2023). Biochemical Correction of GM2 Ganglioside Accumulation in AB-Variant GM2 Gangliosidosis. International Journal of Molecular Sciences. 24(11). 9217–9217. 4 indexed citations
2.
Leduc, Charles, et al.. (2017). Combined targeting of Raf and Mek synergistically inhibits tumorigenesis in triple negative breast cancer model systems. Oncotarget. 8(46). 80804–80819. 24 indexed citations
3.
Rudie, Karen, et al.. (2016). Petri Net Siphon Analysis and Graph Theoretic Measures for Identifying Combination Therapies in Cancer. IEEE/ACM Transactions on Computational Biology and Bioinformatics. 15(1). 231–243. 7 indexed citations
4.
Pastrello, Chiara, Elisa Pasini, Max Kotlyar, et al.. (2014). Integration, visualization and analysis of human interactome. Biochemical and Biophysical Research Communications. 445(4). 757–773. 19 indexed citations
5.
6.
7.
8.
Sangrar, Waheed, Yan Gao, Michelle Scott, Peter Truesdell, & Peter A. Greer. (2007). Fer-Mediated Cortactin Phosphorylation Is Associated with Efficient Fibroblast Migration and Is Dependent on Reactive Oxygen Species Generation during Integrin-Mediated Cell Adhesion. Molecular and Cellular Biology. 27(17). 6140–6152. 72 indexed citations
9.
Sangrar, Waheed, Jeffrey Mewburn, Sandra G. Vincent, John T. Fisher, & Peter A. Greer. (2004). Vascular defects in gain‐of‐function fps/festransgenic mice correlate with PDGF‐ and VEGF‐induced activation of mutant Fps/Fes kinase in endothelial cells. Journal of Thrombosis and Haemostasis. 2(5). 820–832. 6 indexed citations
10.
Sangrar, Waheed, Yan Gao, Barbara Bates, Ralph Zirngibl, & Peter A. Greer. (2004). Activated Fps/Fes tyrosine kinase regulates erythroid differentiation and survival. Experimental Hematology. 32(10). 935–945. 11 indexed citations
11.
Sangrar, Waheed, et al.. (2004). Hemostatic and hematological abnormalities in gain‐of‐function fps/fes transgenic mice are associated with the angiogenic phenotype. Journal of Thrombosis and Haemostasis. 2(11). 2009–2019. 3 indexed citations
12.
Senis, Yotis A., et al.. (2003). Fps/Fes and Fer non-receptor protein-tyrosine kinases regulate collagen- and ADP-induced platelet aggregation. Journal of Thrombosis and Haemostasis. 1(5). 1062–1070. 21 indexed citations
13.
Sangrar, Waheed, et al.. (2003). The fps/fes proto-oncogene regulates hematopoietic lineage output. Experimental Hematology. 31(12). 1259–1267. 11 indexed citations
14.
Sangrar, Waheed & Marlys L. Koschinsky. (2000). Characterization of the interaction of recombinant apolipoprotein(a) with modified fibrinogen surfaces and fibrin clots. Biochemistry and Cell Biology. 78(4). 519–525. 10 indexed citations
15.
Rand, Margaret L., Waheed Sangrar, Mark A. Hancock, et al.. (1998). Apolipoprotein(a) Enhances Platelet Responses to the Thrombin Receptor–Activating Peptide SFLLRN. Arteriosclerosis Thrombosis and Vascular Biology. 18(9). 1393–1399. 67 indexed citations
16.
Sangrar, Waheed, Brent R. Gabel, Michael B. Boffa, et al.. (1997). The Solution Phase Interaction between Apolipoprotein(a) and Plasminogen Inhibits the Binding of Plasminogen to a Plasmin-Modified Fibrinogen Surface. Biochemistry. 36(34). 10353–10363. 46 indexed citations
17.
Biemond, Bart J., Philip W. Friederich, Marlys L. Koschinsky, et al.. (1997). Apolipoprotein(a) Attenuates Endogenous Fibrinolysis in the Rabbit Jugular Vein Thrombosis Model In Vivo. Circulation. 96(5). 1612–1615. 40 indexed citations
18.
Sangrar, Waheed, Laszlo Bajzar, Michael E. Nesheim, & Marlys L. Koschinsky. (1995). Antifibrinolytic Effect of Recombinant Apolipoprotein(a) in Vitro Is Primarily Due to Attenuation of tPA-Mediated Glu-Plasminogen Activation. Biochemistry. 34(15). 5151–5157. 52 indexed citations
19.
Sangrar, Waheed, Santica M. Marcovina, & Marlys L. Koschinsky. (1994). Expression and characterization of apolipoprotein(a) kringle IV types 1, 2 and 10 in mammalian cells. Protein Engineering Design and Selection. 7(5). 723–731. 29 indexed citations
20.
Hoek, Ytje Y. van der, Waheed Sangrar, Graham P. Côté, John J.P. Kastelein, & Marlys L. Koschinsky. (1994). Binding of recombinant apolipoprotein(a) to extracellular matrix proteins.. Arteriosclerosis and Thrombosis A Journal of Vascular Biology. 14(11). 1792–1798. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yi Shi Breakdown of academic impact, for papers by P. Charles Lin Breakdown of academic impact, for papers by Anna Roubtsova Breakdown of academic impact, for papers by Kévin Ly Breakdown of academic impact, for papers by Jose Juarez Breakdown of academic impact, for papers by Qianshan Ding Breakdown of academic impact, for papers by Mark Peek Breakdown of academic impact, for papers by Monica Kong-Beltran Breakdown of academic impact, for papers by Ali Küpelioğlu Breakdown of academic impact, for papers by Ling‐Yuh Huw
Rankless by CCL
2026